Business Description
Genfit S.A. is a French biopharmaceutical company focused on developing treatments and diagnostic tools for serious liver diseases. Its lead drug, elafibranor, is approved for primary biliary cholangitis and is being tested for other liver conditions, while additional compounds are progressing through various stages of clinical and preclinical research. The company also develops non-invasive diagnostic technologies to help identify and monitor liver disease. Genfit works with partners including Ipsen and Labcorp to bring its treatments and diagnostics to patients around the world.
